IKM Stock Overview
1nKemia IUCT Group, S.A. provides research and development, and technological services to chemical, pharmaceutical, biotechnological, cosmetic, nutraceutical, and related industries.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
1nKemia IUCT Group, S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.31 |
| 52 Week High | €0 |
| 52 Week Low | €0 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | 0% |
| 3 Year Change | n/a |
| 5 Year Change | 0% |
| Change since IPO | -63.10% |
Recent News & Updates
Recent updates
Shareholder Returns
| IKM | ES Biotechs | ES Market | |
|---|---|---|---|
| 7D | 0% | -2.7% | 0.5% |
| 1Y | 0% | -13.5% | 11.6% |
Return vs Industry: IKM exceeded the Spanish Biotechs industry which returned -13.5% over the past year.
Return vs Market: IKM underperformed the Spanish Market which returned 11.6% over the past year.
Price Volatility
| IKM volatility | |
|---|---|
| IKM Average Weekly Movement | 0% |
| Biotechs Industry Average Movement | 7.5% |
| Market Average Movement | 3.3% |
| 10% most volatile stocks in ES Market | 6.5% |
| 10% least volatile stocks in ES Market | 0.9% |
Stable Share Price: IKM has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine IKM's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | n/a | Josep Castells Boliart | www.inkemia.com |
1nKemia IUCT Group, S.A. provides research and development, and technological services to chemical, pharmaceutical, biotechnological, cosmetic, nutraceutical, and related industries. It offers customized research and development services; and develops own technological platforms. The company also provides technological services, including analysis in various scientific areas, pharmaceutical production, cosmetic, and nutraceutics; services of consulting and technical audits; scientific knowledge; and conferences, seminars, workshops, and congresses.
1nKemia IUCT Group, S.A. Fundamentals Summary
| IKM fundamental statistics | |
|---|---|
| Market cap | €8.34m |
| Earnings (TTM) | €3.54m |
| Revenue (TTM) | €1.74m |
0.0x
P/E Ratio0.0x
P/S RatioIs IKM overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IKM income statement (TTM) | |
|---|---|
| Revenue | €1.74m |
| Cost of Revenue | -€1.19m |
| Gross Profit | €2.93m |
| Other Expenses | -€617.40k |
| Earnings | €3.54m |
Last Reported Earnings
Dec 31, 2019
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did IKM perform over the long term?
See historical performance and comparison